This application addresses the structural features of the GLP-1 receptor and the ligands GLP-1 and GLP-2 which activate this receptor which in turn leads to cAMP elevations. This receptor system is important in glucose regulation due to its function to promote insulin secretion in pancreatic beta cells and to inhibit glucagon secretion and to delay gastric emptying. The applicant will define residues in the GLP-1 receptor that alter its ability to respond to ligand and its ability to link to G protein function and cAMP regulation. He has made interesting observations relating to these goals, in particular the discovery that there are species differences in GLP-2 binding to GLP-1 receptor from rat vs. human. Preliminary data are presented related to these findings that form the basis of many of the experiments in Aims 1 and 2. These proposed experiments are designed to refine our understanding of the specific residues in both the ligands and the GLP-1 receptor that are key to receptor function, which may lead to the identification of agonists and antagonists that are superior to those now known. Another direction that the experiments will take(Aim 3) is the evaluation of the hypothesis that there is a tonic activity of the GLP-1 receptor that functions in beta cells to modulate insulin secretion even in the absence of ligands. Receptor will be expressed in cell lines derived from beta cells and its ability to modulate cAMP levels in the absence of ligands evaluated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056674-04
Application #
6646447
Study Section
Endocrinology Study Section (END)
Program Officer
Laughlin, Maren R
Project Start
2000-09-01
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2005-08-31
Support Year
4
Fiscal Year
2003
Total Cost
$276,500
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
079532263
City
Boston
State
MA
Country
United States
Zip Code
02111
Masur, Kai; Tibaduiza, Elmi C; Chen, Ci et al. (2005) Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function. Mol Endocrinol 19:1373-82
Beinborn, Martin; Worrall, Christine I; McBride, Edward W et al. (2005) A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness. Regul Pept 130:1-6
Watanabe, Kazuhiro; Beinborn, Martin; Nagamatsu, Shinya et al. (2005) Menetrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity. Scand J Gastroenterol 40:477-81
Beinborn, Martin; Ren, Yong; Blaker, Michael et al. (2004) Ligand function at constitutively active receptor mutants is affected by two distinct yet interacting mechanisms. Mol Pharmacol 65:753-60
Doran, Amanda C; Wan, Yieh-Ping; Kopin, Alan S et al. (2003) Established theory of radiation-induced decay is not generalizable to Bolton-Hunter labeled peptides. Biochem Pharmacol 65:1515-20
Kopin, Alan S; McBride, Edward W; Chen, Ci et al. (2003) Identification of a series of CCK-2 receptor nonpeptide agonists: sensitivity to stereochemistry and a receptor point mutation. Proc Natl Acad Sci U S A 100:5525-30
Tibaduiza, E C; Chen, C; Beinborn, M (2001) A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain. J Biol Chem 276:37787-93